COMT inhibitors (PAION)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameCOMT inhibitors (PAION)
Drug Alias NameCOMT inhibitors (CeNeS)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCatechol-O-methyl transferase inhibitors
TargetsCatechol-O-methyl transferase
Therapy Area/IndicationsSchizophreniaParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCeNeS Pharmaceuticals plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCeNeS Pharmaceuticals plcPaion AG
Active IndicationsN/A
Inactive IndicationsSchizophreniaParkinson Disease

Other Information

ATC CodeN/A
Related LinksN/A